NURA Medical focuses on developing medical devices and technology software aimed at enhancing patient care, particularly in pediatric settings. The company's innovative weight estimation device and medication dosing software streamline the administration process, allowing a single nurse to effectively manage medication delivery. This efficiency helps healthcare organizations optimize their workforce, enabling them to allocate resources to other critical areas, especially during times of staff shortages. NURA Medical's solutions are designed to improve clinical outcomes while addressing the pressing challenges faced by healthcare providers.
Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes. It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay. Creative Destruction Labs supports the company.
Eli is a women's health company on a mission to improve lifelong health by continuously monitoring hormones in saliva. Hormones impact overall health every day and at all stages of life. Yet, traditional testing methods and send-out tests only provide infrequent snapshots. In three simple steps, Eli's at-home technology provides personalized hormone profiles continuously to transform how women manage their hormonal health in key areas like menopause, fertility, contraception, and endocrine conditions.
Arbutus Medical Inc., founded in 2014 and headquartered in Vancouver, Canada, specializes in the development and manufacturing of surgical power tools aimed at enhancing surgical efficiency and accessibility. The company offers a range of products, including its flagship orthopedic power tool system, which features innovative solutions such as the HEX and PRO drill kits, as well as sterile-packed orthopedic procedure kits. These tools are designed to meet the needs of various healthcare settings, including trauma centers, veterinary hospitals, military deployments, and hospitals in over 30 low- and middle-income countries. Arbutus Medical focuses on "frugal innovation," aiming to reduce healthcare costs and improve access to orthopedic surgery for millions of patients by 2030.
LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. The company is creating experiences to assist consumers and employers all over the world in better managing anxiety and stress. They have created wellness-focused experiences that deliver benefits in as little as 5 minutes using innovative human-centered design at the intersection of art, science, and technology.
HALEO Preventive Health Solutions Inc. is a Montréal-based clinic that focuses on enhancing human health and performance by addressing sleep and mental disorders. Established in 2015, the clinic provides tele-psychotherapy services and a mobile application designed to improve access to high-quality care for individuals suffering from sleep-related issues, including insomnia. Through video conferencing, patients can connect with doctors, therapists, and experts who guide them in their treatment. HALEO's services not only aim to improve individual well-being but also assist organizations in mitigating costs associated with productivity losses, accidents, burnout, and disability by promoting better sleep among employees.
Ditch Labs is a digital health company focused on innovative treatment for substance addiction, particularly targeting nicotine addiction. The company combines AI-driven behavioral therapy with advanced drug delivery devices to offer a unique digital therapeutic approach. Ditch Labs develops proprietary nicotine vaporizers that facilitate smoking cessation by gradually and automatically reducing nicotine intake. Accompanying this device is a mobile application that provides behavioral support, helping users navigate their journey to overcome nicotine addiction and promote healthier lifestyles. Through these interconnected solutions, Ditch Labs aims to address one of the leading causes of preventable death globally.
Sonic Incytes is a medical device start-up company developing quantitative ultrasound for point-of-care diagnostic and procedure guidance. our mission to enable routine assessment and management of liver health, with diagnostic accuracy you can count on.
Optina Diagnostics Inc. is a diagnostics company based in Montréal, Canada, founded in 2010. It specializes in the early detection of Alzheimer's disease through innovative hyperspectral imaging technology that examines the retina. By employing non-invasive diagnostic tests, Optina Diagnostics identifies key biomarkers, such as beta-amyloid plaques, which are crucial for assessing patients' health and disease risk. The company's advanced imaging systems also aid in the detection of age-related macular degeneration and ocular diabetic retinopathy, providing physicians with critical information that enables timely and appropriate patient care. Through its focus on retinal features and artificial intelligence, Optina Diagnostics aims to transform the assessment of brain health and address under-diagnosed diseases.
BioMark Diagnostics Inc. is a Canadian oncology-focused company that specializes in developing non-invasive cancer diagnostic solutions to enhance early detection, monitoring, and assessment of treatment. Founded in 2014 and headquartered in Richmond, Canada, the company is a subsidiary of Biomark Technologies Inc. BioMark has established collaborations, including one with the University of Maryland School of Medicine, to discover and validate assays for early lung cancer detection and monitoring of residual tumor activity. The company has developed several intellectual properties related to the detection and quantification of metabolites, aiming to improve patient outcomes through innovative diagnostic technologies. With a dedicated team of scientists, engineers, and medical professionals, BioMark is committed to commercializing its technologies while adhering to the highest regulatory, clinical, and scientific standards to enhance the accuracy of cancer diagnoses.
Qurcan Therapeutics is focused on developing advanced therapeutic solutions for solid tumors, particularly brain cancers. The company has created a nanotechnology-based drug delivery platform that enhances the precision of cancer treatment by overcoming challenges associated with traditional drug delivery methods. This platform improves the release of therapeutic agents while minimizing liver accumulation, allowing for more effective targeting of difficult-to-reach tumors. Among its innovations is Manganescan®, a theranostic agent that serves as both an MRI contrast agent and a radio-sensitizer, enabling early detection of brain tumors and enhancing the effectiveness of radiation therapy. By facilitating improved drug delivery and modulating the tumor microenvironment, Qurcan Therapeutics aims to increase therapeutic efficacy and extend patient survival in the fight against solid tumor cancers.
My Intelligent Machines (MIMs) is a Montreal-based company specializing in artificial intelligence and systems biology. It offers biopharmaceutical companies interactive augmented intelligence systems that facilitate accurate biological simulations during the early stages of drug development. These systems assist life scientists in creating precisely targeted and personalized therapies. MIMs also develops software designed for efficient and personalized medicine and agricultural systems, packaged as a software-as-a-service solution. Its offerings support patient stratification and the selection of therapeutic targets and biomarkers, which are essential for advancing personalized therapies. The company emphasizes open and explainable AI and data integration, enabling life-science organizations to leverage their big data and artificial intelligence capabilities to enhance food and drug production.
Non Equity Assistance in 2021
Ethnocare specializes in designing and manufacturing orthopaedic devices aimed at enhancing the mobility and comfort of amputees. Their flagship product, the Overlay, incorporates an integrated pump system that allows for easy and effective adjustments to the fit of the prosthesis, eliminating the need for traditional prosthetic socks. This innovative device features a flexible sports fabric sleeve and a series of pneumatic cells that respond to changes in the volume of the residual limb, ensuring a consistent and comfortable fit. By adapting to various limb morphologies, Ethnocare's products significantly improve the user experience for those requiring prosthetic devices.
Innovere Medical specializes in the development of wireless peripheral devices aimed at enhancing patient comfort during magnetic resonance imaging (MRI) examinations. The company’s innovative products deliver clear audio signals to patients and significantly reduce MRI noise to a background hum, thereby improving the overall experience. One of its key offerings, MRI-Voicelink, facilitates noiseless and wireless communication between clinicians both inside and outside the MRI suite. This technology not only fosters better communication among medical practitioners but also enhances patient involvement and alleviates anxiety during the imaging process. Through these advancements, Innovere Medical aims to improve the quality of MRI procedures and patient satisfaction.
Eli is a women's health company on a mission to improve lifelong health by continuously monitoring hormones in saliva. Hormones impact overall health every day and at all stages of life. Yet, traditional testing methods and send-out tests only provide infrequent snapshots. In three simple steps, Eli's at-home technology provides personalized hormone profiles continuously to transform how women manage their hormonal health in key areas like menopause, fertility, contraception, and endocrine conditions.
Aifred Health Inc. is a Montreal-based company that specializes in developing a deep-learning clinical decision support tool aimed at enhancing personalized medicine in psychiatry. Founded in 2017, Aifred Health addresses the longstanding challenges associated with the trial-and-error approach to treatment selection in depression, which is a leading cause of medical impairment. The company's application software features treatment prediction, interpretability, patient data tracking, and electronic patient record capabilities. By processing de-identified data, Aifred's AI model generates tailored therapeutic options for individual patients, enabling clinicians to make more informed decisions among various treatment options that may appear effective at a population level but vary significantly in effectiveness for individuals.
SeamlessMD is a digital patient engagement platform focused on improving health outcomes after surgery. By collaborating with healthcare providers, SeamlessMD enhances patient experiences through technology, design, and data. The platform supports hospitals in remote patient monitoring, enabling the collection of data that can lead to better surgical outcomes and reduced readmissions. Ultimately, SeamlessMD aims to deliver quality surgical care while lowering costs, addressing the challenges faced by patients and providers in the surgical process.
ODS Medical Inc. is a Montreal-based medical device company founded in 2015, specializing in the design and manufacture of innovative diagnostic tools for cancer detection. The company's flagship product is a Raman spectroscopy system that enables real-time detection of tissue abnormalities across various clinical settings. By combining advanced optical probes with sophisticated software powered by machine learning algorithms, ODS Medical aims to enhance physicians' decision-making capabilities, providing them with tools that offer high sensitivity, specificity, and accuracy. Through its commitment to developing groundbreaking medical technology, ODS Medical seeks to improve patient outcomes and support healthcare professionals in their diagnostic processes.
Ayogo Health Inc. is a Vancouver-based company that specializes in developing applications and games aimed at managing chronic health conditions and improving patient adherence. Established in 2008, Ayogo employs behavioral psychology and social gaming principles to enhance health outcomes, serving a diverse clientele that includes insurers, healthcare providers, and pharmaceutical companies. The company's flagship product, GoodLife, is a customizable platform featuring gamification elements, incentives, and social interaction, while its suite of Alternate Reality Games integrates online and real-world experiences to facilitate learning. Ayogo's platform is designed to tailor content and support to individual psychosocial factors, promoting patient engagement by fostering activation and adherence to therapy. With a collaborative approach involving patients and clients, Ayogo emphasizes thoughtful innovation within its creative studio environment.
MIMOSA Diagnostics Inc. is a Toronto-based company established in 2016 that specializes in the development of a multispectral mobile tissue assessment device. The company's flagship product, the MIMOSA Pro, is a handheld device that utilizes near-infrared light to non-invasively evaluate tissue health by visualizing biomarkers such as oximetry and temperature beneath the skin's surface, regardless of skin color. This technology aims to enhance patient care by providing immediate insights that can inform treatment decisions, thereby improving outcomes for patients, particularly for those with diabetes who need to monitor their foot health. The device is designed for easy use by both patients and caregivers, streamlining the process of assessing tissue health without the need for extensive testing or long wait times.
Imagia's mission is to leverage advances in artificial intelligence and accelerate the advent of accessible personalized medicine. The company's platform leverage advances in artificial intelligence to provide outcome-based structured clinical data and federated learning capabilities across multiple sources while preserving privacy, enabling clinicians to drive end-to-end discoveries of predictive, diagnostic, and prescriptive analytics.
My Intelligent Machines (MIMs) is a Montreal-based company specializing in artificial intelligence and systems biology. It offers biopharmaceutical companies interactive augmented intelligence systems that facilitate accurate biological simulations during the early stages of drug development. These systems assist life scientists in creating precisely targeted and personalized therapies. MIMs also develops software designed for efficient and personalized medicine and agricultural systems, packaged as a software-as-a-service solution. Its offerings support patient stratification and the selection of therapeutic targets and biomarkers, which are essential for advancing personalized therapies. The company emphasizes open and explainable AI and data integration, enabling life-science organizations to leverage their big data and artificial intelligence capabilities to enhance food and drug production.
Aifred Health Inc. is a Montreal-based company that specializes in developing a deep-learning clinical decision support tool aimed at enhancing personalized medicine in psychiatry. Founded in 2017, Aifred Health addresses the longstanding challenges associated with the trial-and-error approach to treatment selection in depression, which is a leading cause of medical impairment. The company's application software features treatment prediction, interpretability, patient data tracking, and electronic patient record capabilities. By processing de-identified data, Aifred's AI model generates tailored therapeutic options for individual patients, enabling clinicians to make more informed decisions among various treatment options that may appear effective at a population level but vary significantly in effectiveness for individuals.
Rna Diagnostics Inc. is a Toronto-based company focused on cancer diagnostics, particularly through its innovative RNA Disruption Assay (RDA). This diagnostic platform measures tumor response early in cancer treatment, allowing oncologists to evaluate the effectiveness of chemotherapy. By determining the degree of ribosomal RNA disruption, the RDA serves as a biomarker indicating impending cell death, which helps healthcare providers make informed decisions about treatment options. The company aims to enhance patient management by enabling clinicians to avoid ineffective therapies and harmful side effects, ultimately improving patient survival rates. Established in 2010, Rna Diagnostics serves various stakeholders, including patients, physicians, healthcare systems, and clinical research centers across multiple countries, including Canada, Germany, Italy, Japan, Sweden, the United Kingdom, and the United States.
Saccade Analytics Inc., founded in 2016 by Dr. Mimi Galiana, is a Montreal-based company that develops clinical tools for analyzing eye and head movement data to assess brain function. The company's flagship product, InSight, is designed to assist clinicians and therapists in diagnosing and monitoring conditions such as concussions, vestibular disorders, and other neurological issues. Dr. Galiana's extensive 30-year research background at McGill University in eye and head movement analysis laid the foundation for the company's innovative approach. Saccade Analytics aims to enhance the standard of neurological care by translating advanced research into practical, accessible tools for healthcare professionals.
Optina Diagnostics Inc. is a diagnostics company based in Montréal, Canada, founded in 2010. It specializes in the early detection of Alzheimer's disease through innovative hyperspectral imaging technology that examines the retina. By employing non-invasive diagnostic tests, Optina Diagnostics identifies key biomarkers, such as beta-amyloid plaques, which are crucial for assessing patients' health and disease risk. The company's advanced imaging systems also aid in the detection of age-related macular degeneration and ocular diabetic retinopathy, providing physicians with critical information that enables timely and appropriate patient care. Through its focus on retinal features and artificial intelligence, Optina Diagnostics aims to transform the assessment of brain health and address under-diagnosed diseases.
Thorasys Thoracic Medical Systems Inc. is a Montreal-based company specializing in respiratory medical devices. The company focuses on developing innovative pulmonary diagnostic technologies aimed at diagnosing and monitoring lung diseases, including asthma and chronic obstructive pulmonary disease. Utilizing a forced oscillation technique, Thorasys provides equipment that enables healthcare professionals to measure lung capacity across diverse patient populations. This technology facilitates early detection of lung diseases, enhancing the ability to monitor respiratory health effectively.
Spinologics Inc, founded in 2010 and headquartered in Montréal, Canada, specializes in the development and manufacturing of innovative spinal care products. The company offers a range of devices, including Scolioscreen, which enables the use of smartphones to screen for spinal deformities, and the Scolioscreen APP, designed to measure trunk rotation angles. Additionally, Spinologics produces Cervision, a tool that helps maintain patients' shoulders and arms during procedures, ultimately reducing surgery time and providing x-rays of the cervical spine. The company also operates a Biomechanics Numerical Lab, which focuses on the design of medical devices and provides consulting services in biomechanics. Spinologics aims to address unmet clinical needs by leveraging its expertise in spine-related technologies to enhance surgical techniques and improve patient outcomes.
MY01 Inc. is a Montreal-based company that designs and develops a digital medical device specifically for measuring muscle pressure, which is critical for diagnosing Acute Compartment Syndrome (ACS). Founded in 2015, MY01 focuses on providing real-time and accurate measurements that enable timely clinical decisions. The company's sensor technology utilizes capacitive pressure sensors featuring a stable vacuum reference and advanced coating materials, ensuring tailored sensing capabilities. This innovative approach enhances the sensitivity and specificity of ACS diagnostics, equipping medical professionals with essential tools for effective patient care.
Spring Loaded Technology Inc. designs and manufactures innovative bionic knee braces aimed at enhancing mobility and reducing pain for various users. The company's flagship product, the Levitation knee brace, is the first compact device of its kind that improves leg muscle power output, making it beneficial for athletes and individuals with knee injuries or mobility impairments. The product line includes specialized models such as the UpShot tactical knee brace, designed to prevent injuries during intense activities, and the Levitation Ski knee brace, which helps reduce muscle fatigue and joint pain for skiers. These braces cater to a wide range of activities, including weight lifting, running, cycling, and various skilled trades, supporting those with conditions like osteoarthritis and knee injuries. Established in 2012 in Dartmouth, Canada, Spring Loaded sells its products online, focusing on enhancing performance and restoring mobility for its users.
Densitas Inc. is a Canadian company that specializes in developing advanced breast imaging analytics technologies for healthcare systems and radiology departments. Founded in 2011, Densitas offers a web-based analytics platform known as densitasenterprise, which includes several components: densitasdensity for assessing breast tissue density according to the ACR BI-RADS scale, densitasquality for evaluating image quality, and densitasrisk for providing breast cancer risk assessments. These solutions leverage artificial intelligence to deliver on-demand insights that facilitate risk-based patient management, enabling healthcare administrators to monitor clinical and operational performance metrics. The platform is designed to integrate with existing workflows, utilizing standard DICOM images to support both point-of-care and retrospective analysis of mammograms. Densitas aims to enhance diagnostic accuracy and improve patient outcomes in breast cancer screening.
Aerial's technology leverages existing infrastructure to recognize activity without the need for cameras, sensors or wearables. Aerial's patented technology analyzes distortions and fluctuations in the existing wireless signals and uses AI to interpret them and classify human activities.